Oral Antibiotic Options for Enterococcus Complicated UTI
For complicated UTIs caused by enterococcus, fosfomycin (3g single dose) is the oral antibiotic of choice due to its excellent efficacy against vancomycin-resistant enterococci (VRE) and favorable safety profile. 1
First-Line Options (in order of preference)
Fosfomycin
Nitrofurantoin
Amoxicillin/Ampicillin
Second-Line Options
Linezolid
Doxycycline
Treatment Algorithm
Obtain urine culture and susceptibility testing before initiating therapy
- Essential to guide appropriate antibiotic selection 1
For initial empiric therapy (pending cultures):
- If low suspicion for resistance: Fosfomycin 3g single dose OR Nitrofurantoin 100mg PO q6h
- If high suspicion for resistance (healthcare-associated, recent antibiotics): Consider linezolid 600mg PO q12h
Once susceptibilities are available:
- If ampicillin-susceptible: Use amoxicillin 500mg PO q8h
- If ampicillin-resistant but nitrofurantoin/fosfomycin-susceptible: Use either nitrofurantoin or fosfomycin
- If multi-drug resistant: Use linezolid 600mg PO q12h
Treatment duration:
- Fosfomycin: Single 3g dose
- Nitrofurantoin: 5-7 days
- Amoxicillin/ampicillin: 5-7 days
- Linezolid: 7-14 days (based on clinical response)
Special Considerations
- Vancomycin-resistant enterococci (VRE): Fosfomycin, nitrofurantoin, and linezolid are effective options 2, 3
- Renal impairment: Avoid nitrofurantoin if CrCl <60 mL/min 1
- Severe infection/upper UTI: Consider parenteral therapy initially with linezolid or daptomycin 3
- Asymptomatic bacteriuria: Treatment not recommended unless in pregnant women or before invasive urologic procedures 1, 3
Monitoring
- Monitor clinical response within 48-72 hours
- For linezolid: Monitor complete blood count weekly if treatment extends beyond 14 days due to risk of thrombocytopenia 4
- Follow-up urine culture may be warranted in complicated cases or treatment failures
Pitfalls to Avoid
- Treating asymptomatic bacteriuria with enterococci, which is common and rarely requires treatment 5
- Using fluoroquinolones empirically due to increasing resistance rates 1
- Failing to remove urinary catheters when possible, as they serve as a nidus for infection 6
- Using linezolid for extended periods without monitoring for hematologic toxicity 3
Remember that enterococci are a common cause of UTIs among hospitalized patients, and the rising prevalence of VRE is concerning due to limited treatment options and association with increased mortality and healthcare costs 3.